Eric Yee
Concepts (236)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ampulla of Vater | 4 | 2018 | 19 | 1.190 |
Why?
| Intestinal Mucosa | 3 | 2020 | 291 | 0.850 |
Why?
| Gastritis | 1 | 2018 | 28 | 0.720 |
Why?
| Colitis | 4 | 2020 | 58 | 0.720 |
Why?
| Crohn Disease | 4 | 2021 | 89 | 0.720 |
Why?
| Adenoma, Liver Cell | 1 | 2016 | 12 | 0.640 |
Why?
| Placenta Diseases | 1 | 2016 | 12 | 0.640 |
Why?
| Pregnancy Complications, Neoplastic | 1 | 2016 | 20 | 0.630 |
Why?
| Adenosine Deaminase | 3 | 2021 | 4 | 0.460 |
Why?
| Liver Cirrhosis | 3 | 2018 | 206 | 0.450 |
Why?
| Gastrointestinal Agents | 2 | 2021 | 36 | 0.430 |
Why?
| Brenner Tumor | 1 | 2010 | 1 | 0.430 |
Why?
| Pancreatic Neoplasms | 3 | 2018 | 219 | 0.410 |
Why?
| Immunity, Innate | 3 | 2020 | 108 | 0.400 |
Why?
| Cannabidiol | 2 | 2020 | 32 | 0.390 |
Why?
| Magnetic Resonance Imaging | 6 | 2020 | 1658 | 0.390 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2021 | 134 | 0.390 |
Why?
| Antibodies, Monoclonal, Humanized | 2 | 2021 | 222 | 0.380 |
Why?
| Liver | 6 | 2022 | 1247 | 0.350 |
Why?
| Adenosine Triphosphatases | 2 | 2017 | 74 | 0.340 |
Why?
| Common Bile Duct Diseases | 2 | 2015 | 8 | 0.310 |
Why?
| Carcinoma, Renal Cell | 2 | 2020 | 124 | 0.310 |
Why?
| Colitis, Ulcerative | 2 | 2016 | 49 | 0.300 |
Why?
| Ovarian Neoplasms | 1 | 2010 | 441 | 0.300 |
Why?
| Humans | 32 | 2021 | 51226 | 0.290 |
Why?
| Kidney Neoplasms | 2 | 2020 | 203 | 0.290 |
Why?
| Membrane Proteins | 2 | 2018 | 382 | 0.280 |
Why?
| Immunohistochemistry | 4 | 2018 | 1135 | 0.270 |
Why?
| Colonoscopy | 3 | 2020 | 107 | 0.250 |
Why?
| Autocrine Communication | 1 | 2021 | 10 | 0.240 |
Why?
| Kupffer Cells | 1 | 2021 | 18 | 0.240 |
Why?
| Paracrine Communication | 1 | 2021 | 17 | 0.230 |
Why?
| Biopsy | 3 | 2020 | 690 | 0.230 |
Why?
| Biological Factors | 1 | 2021 | 8 | 0.230 |
Why?
| Cannabis | 2 | 2020 | 109 | 0.230 |
Why?
| Female | 19 | 2021 | 28342 | 0.220 |
Why?
| Common Bile Duct Neoplasms | 3 | 2015 | 12 | 0.220 |
Why?
| Toll-Like Receptor 9 | 1 | 2020 | 12 | 0.220 |
Why?
| Enterotoxins | 1 | 2020 | 12 | 0.220 |
Why?
| Endoscopy, Gastrointestinal | 2 | 2018 | 72 | 0.220 |
Why?
| Monocytes | 1 | 2021 | 159 | 0.220 |
Why?
| Predictive Value of Tests | 3 | 2020 | 1051 | 0.220 |
Why?
| Liver Neoplasms | 2 | 2015 | 326 | 0.220 |
Why?
| Colon | 2 | 2020 | 113 | 0.210 |
Why?
| Plant Extracts | 2 | 2020 | 202 | 0.210 |
Why?
| Adult | 13 | 2021 | 14064 | 0.210 |
Why?
| Bacterial Toxins | 1 | 2020 | 63 | 0.210 |
Why?
| Abdomen | 1 | 2020 | 80 | 0.210 |
Why?
| Apyrase | 2 | 2017 | 17 | 0.210 |
Why?
| Clostridium Infections | 1 | 2020 | 61 | 0.200 |
Why?
| Hepatic Veno-Occlusive Disease | 1 | 2019 | 8 | 0.200 |
Why?
| Alanine Transaminase | 1 | 2020 | 150 | 0.200 |
Why?
| Methionine | 1 | 2020 | 142 | 0.200 |
Why?
| Mice | 9 | 2020 | 6254 | 0.200 |
Why?
| Methamphetamine | 1 | 2022 | 227 | 0.200 |
Why?
| Colonic Pouches | 2 | 2015 | 7 | 0.200 |
Why?
| Male | 19 | 2022 | 27647 | 0.190 |
Why?
| Gastrointestinal Tract | 1 | 2020 | 135 | 0.190 |
Why?
| Cell Proliferation | 3 | 2018 | 1120 | 0.190 |
Why?
| Acetaminophen | 2 | 2020 | 346 | 0.190 |
Why?
| Claudin-1 | 1 | 2018 | 5 | 0.190 |
Why?
| Zonula Occludens-1 Protein | 1 | 2018 | 7 | 0.190 |
Why?
| Lipase | 1 | 2018 | 19 | 0.180 |
Why?
| Observer Variation | 1 | 2018 | 147 | 0.180 |
Why?
| Cation Transport Proteins | 1 | 2018 | 27 | 0.180 |
Why?
| Enteric Nervous System | 1 | 2017 | 2 | 0.180 |
Why?
| Bile Duct Neoplasms | 1 | 2017 | 29 | 0.180 |
Why?
| Cholangiocarcinoma | 1 | 2017 | 27 | 0.180 |
Why?
| Transcriptome | 2 | 2020 | 329 | 0.180 |
Why?
| Serum | 1 | 2017 | 40 | 0.180 |
Why?
| Lanthanum | 1 | 2017 | 3 | 0.170 |
Why?
| Liver Regeneration | 1 | 2017 | 61 | 0.170 |
Why?
| Upper Gastrointestinal Tract | 1 | 2017 | 4 | 0.170 |
Why?
| Hyperphosphatemia | 1 | 2017 | 2 | 0.170 |
Why?
| Transaminases | 1 | 2017 | 12 | 0.170 |
Why?
| Anorexia Nervosa | 1 | 2017 | 6 | 0.170 |
Why?
| Pneumatosis Cystoides Intestinalis | 1 | 2017 | 7 | 0.170 |
Why?
| Decision Support Techniques | 1 | 2017 | 83 | 0.170 |
Why?
| Paneth Cells | 1 | 2016 | 3 | 0.170 |
Why?
| Diffusion Magnetic Resonance Imaging | 1 | 2017 | 125 | 0.160 |
Why?
| Immunity, Mucosal | 1 | 2016 | 19 | 0.160 |
Why?
| Retrospective Studies | 5 | 2021 | 5788 | 0.160 |
Why?
| Middle Aged | 12 | 2021 | 13329 | 0.160 |
Why?
| Cholangitis, Sclerosing | 1 | 2016 | 8 | 0.160 |
Why?
| Insulinoma | 1 | 2016 | 7 | 0.160 |
Why?
| Pregnancy, Twin | 1 | 2016 | 7 | 0.160 |
Why?
| Dietary Supplements | 1 | 2020 | 442 | 0.160 |
Why?
| Th1 Cells | 1 | 2016 | 49 | 0.160 |
Why?
| Adaptive Immunity | 1 | 2016 | 38 | 0.160 |
Why?
| Enteral Nutrition | 1 | 2017 | 131 | 0.160 |
Why?
| Th17 Cells | 1 | 2016 | 24 | 0.160 |
Why?
| Hepatitis, Autoimmune | 1 | 2016 | 31 | 0.160 |
Why?
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 26 | 0.160 |
Why?
| Incidental Findings | 1 | 2016 | 44 | 0.160 |
Why?
| Adenomatous Polyposis Coli | 1 | 2015 | 7 | 0.160 |
Why?
| Animals | 10 | 2022 | 14412 | 0.160 |
Why?
| Gene Expression Regulation, Neoplastic | 2 | 2018 | 880 | 0.160 |
Why?
| Multidetector Computed Tomography | 1 | 2015 | 9 | 0.150 |
Why?
| Bariatric Surgery | 1 | 2016 | 35 | 0.150 |
Why?
| Serine Endopeptidases | 1 | 2016 | 60 | 0.150 |
Why?
| Diagnosis, Differential | 5 | 2020 | 1168 | 0.150 |
Why?
| Hypoglycemia | 1 | 2016 | 63 | 0.150 |
Why?
| Angiomyolipoma | 1 | 2015 | 11 | 0.150 |
Why?
| Fatty Acids | 1 | 2016 | 171 | 0.150 |
Why?
| Rectal Neoplasms | 1 | 2015 | 48 | 0.150 |
Why?
| Proto-Oncogene Proteins | 1 | 2016 | 171 | 0.150 |
Why?
| Inflammatory Bowel Diseases | 1 | 2015 | 50 | 0.150 |
Why?
| Kwashiorkor | 1 | 2014 | 2 | 0.150 |
Why?
| Paraganglioma | 1 | 2014 | 13 | 0.140 |
Why?
| Gastric Bypass | 1 | 2014 | 23 | 0.140 |
Why?
| Antigens, CD | 1 | 2016 | 264 | 0.140 |
Why?
| Neoplasms, Muscle Tissue | 1 | 2014 | 13 | 0.140 |
Why?
| Tomography, X-Ray Computed | 3 | 2015 | 1280 | 0.140 |
Why?
| Macrophages | 1 | 2017 | 398 | 0.140 |
Why?
| Reproducibility of Results | 1 | 2018 | 1287 | 0.140 |
Why?
| Gastrointestinal Hemorrhage | 1 | 2014 | 80 | 0.130 |
Why?
| Dacryocystitis | 1 | 2013 | 5 | 0.130 |
Why?
| Nasolacrimal Duct | 1 | 2013 | 10 | 0.130 |
Why?
| Disease Models, Animal | 4 | 2020 | 1659 | 0.130 |
Why?
| Colorectal Neoplasms | 1 | 2015 | 213 | 0.130 |
Why?
| Aged | 8 | 2021 | 10169 | 0.130 |
Why?
| Mice, Inbred C57BL | 4 | 2020 | 2029 | 0.130 |
Why?
| Anesthetics, Local | 1 | 2013 | 74 | 0.130 |
Why?
| Cocaine | 1 | 2013 | 176 | 0.120 |
Why?
| Adenocarcinoma | 1 | 2016 | 428 | 0.110 |
Why?
| Sensitivity and Specificity | 3 | 2020 | 960 | 0.110 |
Why?
| Mice, Knockout | 3 | 2020 | 986 | 0.110 |
Why?
| Sulfonamides | 1 | 2012 | 143 | 0.110 |
Why?
| Pyrimidines | 1 | 2012 | 195 | 0.110 |
Why?
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2010 | 4 | 0.110 |
Why?
| CA-125 Antigen | 1 | 2010 | 20 | 0.110 |
Why?
| Carcinoembryonic Antigen | 1 | 2010 | 15 | 0.110 |
Why?
| Rats, Wistar | 2 | 2022 | 259 | 0.110 |
Why?
| Protein Kinase Inhibitors | 1 | 2012 | 211 | 0.110 |
Why?
| Cocaine-Related Disorders | 1 | 2013 | 256 | 0.100 |
Why?
| Pregnancy | 1 | 2016 | 2461 | 0.090 |
Why?
| Prospective Studies | 3 | 2021 | 2395 | 0.090 |
Why?
| Postoperative Complications | 1 | 2015 | 1020 | 0.090 |
Why?
| Dextran Sulfate | 2 | 2017 | 9 | 0.090 |
Why?
| Liver Function Tests | 2 | 2017 | 48 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 2 | 2020 | 1556 | 0.080 |
Why?
| Disease Progression | 2 | 2018 | 879 | 0.070 |
Why?
| Young Adult | 3 | 2020 | 4171 | 0.070 |
Why?
| Rats | 2 | 2022 | 3493 | 0.070 |
Why?
| Case-Control Studies | 2 | 2017 | 1243 | 0.060 |
Why?
| Proto-Oncogene Proteins c-sis | 1 | 2021 | 11 | 0.060 |
Why?
| Amphetamine | 1 | 2022 | 45 | 0.060 |
Why?
| Half-Life | 1 | 2022 | 100 | 0.060 |
Why?
| Adolescent | 3 | 2020 | 6735 | 0.060 |
Why?
| Signal Transduction | 2 | 2020 | 1812 | 0.060 |
Why?
| Anti-Bacterial Agents | 2 | 2020 | 763 | 0.050 |
Why?
| Mucin-2 | 1 | 2020 | 8 | 0.050 |
Why?
| Aged, 80 and over | 2 | 2020 | 3550 | 0.050 |
Why?
| Adenosylhomocysteinase | 1 | 2020 | 11 | 0.050 |
Why?
| Molecular Chaperones | 1 | 2020 | 65 | 0.050 |
Why?
| Drug Monitoring | 1 | 2020 | 90 | 0.050 |
Why?
| Aldehyde Dehydrogenase | 1 | 2020 | 28 | 0.050 |
Why?
| Alcohol Dehydrogenase | 1 | 2020 | 40 | 0.050 |
Why?
| Ileum | 1 | 2020 | 115 | 0.050 |
Why?
| Chemokines | 1 | 2020 | 96 | 0.050 |
Why?
| DNA, Bacterial | 1 | 2020 | 183 | 0.050 |
Why?
| Treatment Outcome | 2 | 2021 | 5480 | 0.050 |
Why?
| Drug Synergism | 1 | 2019 | 169 | 0.050 |
Why?
| Mice, Inbred Strains | 1 | 2019 | 206 | 0.050 |
Why?
| Epithelial Cells | 1 | 2021 | 294 | 0.050 |
Why?
| Drug Overdose | 1 | 2020 | 130 | 0.050 |
Why?
| Lipoproteins, VLDL | 1 | 2018 | 17 | 0.050 |
Why?
| Lipoproteins, HDL | 1 | 2018 | 19 | 0.050 |
Why?
| Evaluation Studies as Topic | 1 | 2017 | 114 | 0.040 |
Why?
| Body Weight | 1 | 2020 | 587 | 0.040 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2018 | 54 | 0.040 |
Why?
| Neoplasm Grading | 1 | 2017 | 132 | 0.040 |
Why?
| Refeeding Syndrome | 1 | 2017 | 1 | 0.040 |
Why?
| Dexamethasone | 1 | 2020 | 399 | 0.040 |
Why?
| Bile Ducts | 1 | 2017 | 50 | 0.040 |
Why?
| Hepatitis | 1 | 2017 | 21 | 0.040 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2018 | 253 | 0.040 |
Why?
| ROC Curve | 1 | 2017 | 256 | 0.040 |
Why?
| Receptor, Adenosine A2A | 1 | 2016 | 3 | 0.040 |
Why?
| Cell Movement | 1 | 2018 | 303 | 0.040 |
Why?
| Risk Factors | 2 | 2016 | 3924 | 0.040 |
Why?
| RNA, Messenger | 1 | 2020 | 1254 | 0.040 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2016 | 45 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2020 | 1077 | 0.040 |
Why?
| Genotype | 1 | 2018 | 612 | 0.040 |
Why?
| Algorithms | 1 | 2020 | 699 | 0.040 |
Why?
| Cytokines | 1 | 2020 | 683 | 0.040 |
Why?
| Interleukin-17 | 1 | 2016 | 40 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2018 | 448 | 0.040 |
Why?
| Phosphoric Diester Hydrolases | 1 | 2016 | 47 | 0.040 |
Why?
| Malnutrition | 1 | 2017 | 80 | 0.040 |
Why?
| Lipoproteins, LDL | 1 | 2018 | 211 | 0.040 |
Why?
| Anastomosis, Surgical | 1 | 2015 | 73 | 0.040 |
Why?
| Carcinoma in Situ | 1 | 2016 | 71 | 0.040 |
Why?
| Postoperative Period | 1 | 2016 | 184 | 0.040 |
Why?
| Organometallic Compounds | 1 | 2015 | 50 | 0.040 |
Why?
| Colonic Polyps | 1 | 2015 | 45 | 0.040 |
Why?
| Obesity, Morbid | 1 | 2016 | 80 | 0.040 |
Why?
| Pancreatic Function Tests | 1 | 2014 | 1 | 0.040 |
Why?
| Malabsorption Syndromes | 1 | 2014 | 9 | 0.040 |
Why?
| Endoscopy | 1 | 2016 | 115 | 0.040 |
Why?
| Neoplasm Staging | 1 | 2018 | 799 | 0.040 |
Why?
| Image Enhancement | 1 | 2015 | 70 | 0.040 |
Why?
| Kidney Failure, Chronic | 1 | 2017 | 219 | 0.040 |
Why?
| Early Detection of Cancer | 1 | 2016 | 130 | 0.040 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2018 | 543 | 0.040 |
Why?
| Population Surveillance | 1 | 2015 | 185 | 0.040 |
Why?
| Mammary Glands, Human | 1 | 2014 | 19 | 0.040 |
Why?
| Genetic Predisposition to Disease | 1 | 2018 | 568 | 0.030 |
Why?
| Ultrasonography, Doppler, Color | 1 | 2014 | 33 | 0.030 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 699 | 0.030 |
Why?
| Blotting, Western | 1 | 2016 | 712 | 0.030 |
Why?
| Recurrence | 1 | 2016 | 690 | 0.030 |
Why?
| Lacrimal Duct Obstruction | 1 | 2013 | 6 | 0.030 |
Why?
| Contrast Media | 1 | 2015 | 237 | 0.030 |
Why?
| Administration, Intranasal | 1 | 2013 | 28 | 0.030 |
Why?
| Dacryocystorhinostomy | 1 | 2013 | 9 | 0.030 |
Why?
| Body Mass Index | 1 | 2017 | 685 | 0.030 |
Why?
| Models, Biological | 1 | 2018 | 846 | 0.030 |
Why?
| Azithromycin | 1 | 2013 | 37 | 0.030 |
Why?
| Fluoroquinolones | 1 | 2013 | 28 | 0.030 |
Why?
| Cell Line, Tumor | 1 | 2018 | 1476 | 0.030 |
Why?
| Gene Expression | 1 | 2016 | 708 | 0.030 |
Why?
| Flow Cytometry | 1 | 2016 | 583 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2017 | 1505 | 0.030 |
Why?
| Indazoles | 1 | 2012 | 52 | 0.030 |
Why?
| Mass Screening | 1 | 2015 | 370 | 0.030 |
Why?
| Fatal Outcome | 1 | 2012 | 231 | 0.030 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2012 | 222 | 0.030 |
Why?
| Combined Modality Therapy | 1 | 2013 | 703 | 0.030 |
Why?
| Prognosis | 1 | 2016 | 2077 | 0.030 |
Why?
| Follow-Up Studies | 1 | 2016 | 2403 | 0.030 |
Why?
| Time Factors | 1 | 2016 | 3392 | 0.020 |
Why?
| Infant | 1 | 2016 | 3600 | 0.020 |
Why?
| Child, Preschool | 1 | 2016 | 4068 | 0.020 |
Why?
| Child | 1 | 2016 | 6663 | 0.020 |
Why?
|
|
Yee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|